ULBI — Stock Film
STOCK FILMSCENE 1/12ULBI · $5.60
Stock Expert AI presents
ULBI
Ultralife Corporation
~5 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
Ultralife Corporation. What it actually does.

Designs and manufactures power and communication systems. Offers lithium 9-volt, cylindrical, and thin lithium manganese dioxide batteries. Now — the numbers.

on the stock market since 1992
678 employees
$93.3M market value
WHERE DOES THE MONEY COME FROM?
82%Battery & Energy Products
Battery & Energy ProductsCommunications Systems 18%
82% of all revenue comes from a single line: Battery & Energy Products.

That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.

Revenue last year:
$191.2M
The loss that same year:
$5.9M
Sales don’t cover the costs; the gap drains from the cash pile every year.

The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.

THE SALES TREND
Sales are growing, year after year.

Average growth of 18% a year over the last 4 years. Red columns mark years that ended in a loss.

$98.3M
2021
2022
2023
2024
$191.2M
2025
In the vault right now:
$9.3M
DEBT: $49.7M
At this pace, that money lasts about 1.6 years.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

THE PRICE TAG
MARKET VALUE / ANNUAL SALES
0.5×

This company is not turning a profit, so the market is pricing its sales instead: 0.5× for every dollar of annual revenue.

Against companies in its own sector, it looks cheaper than 76% of them.

No analyst target is on record for this company.

What executives did with their own stock over the last 12 months:
20 buy0 sell

Executives buying with their own money is usually read as confidence in the company’s future.

THE FIVE-YEAR JOURNEY
Below the peak, but no collapse.

The stock trades 58% below its peak. The market has trimmed its expectations for the company.

1
THE BRIGHT SIDE · 1/3
Sales keep climbing

Over the last 4 years, sales grew about 18% a year on average.

2
THE BRIGHT SIDE · 2/3
The product is selling

Sales run at $191.2M a year. A small number, but proof the product has real buyers.

3
THE BRIGHT SIDE · 3/3
Executives are buying their own stock

Over the last 12 months, company executives reported 20 buys and 0 sells. Management buying with its own money is usually read as a good sign.

1
THE RISKS · 1/2
Small scale, thin loss

A loss of $5.9M against $191.2M in annual sales.

2
THE RISKS · 2/2
The cash has a countdown

At the current pace of spending, the cash lasts about 1.6 years. After that, the company needs to find new money.

FINALE · THE GRADE
D
38 / 100 · MoonshotScore

On our five-subject report card, ULBI sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: ULBI is a high-risk stock — not yet profitable, and its future rides on its product catching on.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Sep 11, 2026 · stockexpertai.com · Stock Film